-month trial of
compression stockings before intervention for patients with
C2 disease, required by some Insurance companies.
Compression therapy was found to be inferior to minimally
invasive endovenous therapies (including UGFS and
endovenous thermal ablation) that produce better results
with regards to anatomical disease extent, patient
satisfaction and QOL.

Probably no

How substantial are the
undesirable anticipated
effects?

Reported side effects of discomfort, appearance, and
